Inventor · disambiguated record
Ernest J. Mceachern
Also filed as: MCEACHERN ERNEST · MCEACHERN ERNEST J · MCEACHERN ERNEST JOHN
46 granted patents·16 pending applications·580 citations·filing 1999–2022
98Inventor score
Top patents by PatentIndex Score
62 records- 0196US7863293B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2007·Granted Jan 4, 2011·24 cites·18 claims
- 0295US7291631B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2004·Granted Nov 6, 2007·50 cites·25 claims
- 0394US9120781B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2011·Granted Sep 1, 2015·29 cites·6 claims
- 0494US7452994B2Synthesis of enantiomerically pure amino-substituted fused bicyclic ringsANORMED INC·Filed 2006·Granted Nov 18, 2008·18 cites·11 claims
- 0594US7354934B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2005·Granted Apr 8, 2008·34 cites·10 claims
- 0694US6864265B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Mar 8, 2005·42 cites·6 claims
- 0794US6825351B2Synthesis of enantiomerically pure amino-substituted fused bicyclic ringsANORMED INC·Filed 2002·Granted Nov 30, 2004·34 cites·7 claims
- 0894US6750348B1Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2000·Granted Jun 15, 2004·61 cites·30 claims
- 0993US7091217B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Aug 15, 2006·31 cites·12 claims
- 1093US6835731B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Dec 28, 2004·53 cites·10 claims
- 1193US6734191B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted May 11, 2004·35 cites·15 claims
- 1290US7354932B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2003·Granted Apr 8, 2008·27 cites·21 claims
- 1389US8778967B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2012·Granted Jul 15, 2014·18 cites·20 claims
- 1488US8541441B2Selective glycosidase inhibitors and uses thereofVOCADLO DAVID JARO·Filed 2009·Granted Sep 24, 2013·16 cites·4 claims
- 1588US7135570B2Synthesis of enantiomerically pure amino-substituted fused bicyclic ringsANORMED INC·Filed 2004·Granted Nov 14, 2006·18 cites·10 claims
- 1686US8334310B2Selective glycosidase inhibitors and uses thereofVOCADLO DAVID·Filed 2007·Granted Dec 18, 2012·16 cites·4 claims
- 1784US7550484B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2004·Granted Jun 23, 2009·19 cites·11 claims
- 1882US9243020B2Selective glycosidase inhibitors and uses thereofKAUL RAMESH·Filed 2011·Granted Jan 26, 2016·7 cites·45 claims
- 1981US8962664B2Selective glycosidase inhibitors and uses thereofVOCADLO DAVID·Filed 2012·Granted Feb 24, 2015·8 cites·17 claims
- 2081US8927507B2Selective glycosidase inhibitors and uses thereofMCEACHERN ERNEST J·Filed 2012·Granted Jan 6, 2015·9 cites·21 claims
- 2180US9938299B2Glycosidase inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Apr 10, 2018·5 cites·15 claims
- 2278US9522883B2Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Granted Dec 20, 2016·2 cites·9 claims
- 2376US7396840B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Jul 8, 2008·1 cites·9 claims
- 2475US10322111B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2016·Granted Jun 18, 2019·1 cites·13 claims
- 2575US7312234B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Dec 25, 2007·7 cites·6 claims
- 2674US9796680B2Glucocerebrosidase modulators and uses thereofALECTOS THERAPEUTICS INC·Filed 2014·Granted Oct 24, 2017·2 cites·14 claims
- 2773US7629337B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Dec 8, 2009·1 cites·9 claims
- 2872US9409924B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2012·Granted Aug 9, 2016·2 cites·21 claims
- 2971US9199949B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2012·Granted Dec 1, 2015·1 cites·7 claims
- 3070US8901087B2Selective glycosidase inhibitors and uses thereofCHANG JIANG·Filed 2011·Granted Dec 2, 2014·1 cites·43 claims
- 3169US7084155B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Aug 1, 2006·3 cites·15 claims
- 3267US9126957B2Selective glycosidase inhibitors and uses thereofSELNICK HAROLD G·Filed 2012·Granted Sep 8, 2015·1 cites·19 claims
- 3367US7183273B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Feb 27, 2007·2 cites·10 claims
- 3467US2020000774A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2019·Application pending·0 cites
- 3563US2015038509A1Chemokine Receptor Binding Heterocyclic Compounds With Enhanced EfficacyGENZYME CORP·Filed 2014·Application pending·0 cites
- 3662US7807694B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Oct 5, 2010·0 cites·4 claims
- 3762US2008167341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2008·Application pending·0 cites
- 3861US2010105915A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 3959US9079868B2Selective glycosidase inhibitors and uses thereofVOCADLO DAVID JARO·Filed 2009·Granted Jul 14, 2015·0 cites·4 claims
- 4059US2009281308A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 4159US2022409589A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2022·Application pending·0 cites
- 4257US2015299122A1Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4357US2008090846A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY·Filed 2007·Application pending·0 cites
- 4454US2023174486A1Non-lysosomal glucosylceramidase inhibitors and uses thereofALECTOS THERAPEUTICS LNC·Filed 2021·Application pending·0 cites
- 4553US9701693B2Selective glycosidase inhibitors and uses thereofLI TONG-SHUANG·Filed 2012·Granted Jul 11, 2017·0 cites·7 claims
- 4652US10081601B2Glucocerebrosidase modulators and uses thereofALECTOS THERAPEUTICS INC·Filed 2017·Granted Sep 25, 2018·0 cites·11 claims
- 4752US7790747B2Chemokine receptor binding compoundsGENZYME CORP·Filed 2006·Granted Sep 7, 2010·0 cites·14 claims
- 4852US2017107180A1Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4951US9809537B2Glycosidase inhibitors and uses thereofALECTOS THERAPEUTICS INC·Filed 2013·Granted Nov 7, 2017·0 cites·6 claims
- 5051US2011301217A1Selective Glycosidase Inhibitors and Uses ThereofVOCADLO DAVID JARO·Filed 2009·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ernest J. Mceachern files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →